Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes

Background and objectives: The therapeutic effects of the dopamine D2 receptor (D2R) agonist, bromocriptine, in type 2 diabetes (T2D) have been attributed to central nervous system actions. However, peripheral dopamine directly modulates glucose uptake in insulin-sensitive tissues and lipid metaboli...

Full description

Bibliographic Details
Main Authors:	G. Tavares, D. Marques, C. Barra, D. Rosendo-Silva, A. Costa, T. Rodrigues, P. Gasparini, B.F. Melo, J.F. Sacramento, R. Seiça, S.V. Conde, P. Matafome
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	Molecular Metabolism
Subjects:	Type 2 diabetes Obesity Dopamine Bromocriptine D2 dopamine receptor Adipose tissue
Online Access:	http://www.sciencedirect.com/science/article/pii/S2212877821000867

Similar Items

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
by: Via MA
Published: (2010-03-01)

Bromocriptine and insulin sensitivity in lean and obese subjects
by: L Bahler, et al.
Published: (2016-11-01)

Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet
by: Michael Ezrokhi, et al.
Published: (2021-06-01)

Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
by: Maria de Fátima de Magalhães Gonzaga, et al.
Published: (2018-11-01)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
by: Xiaoshuang Liu, et al.
Published: (2019-01-01)

EFFECTS OF ENDOPHYTE-INFECTED TALL FESCUE SEED AND BROMOCRIPTINE ON ENDOCRINE AND IMMUNE FUNCTION IN HORSES
by: Hanneman, Jessica Marie
Published: (2018)

Bromocriptine does not alter speed-accuracy tradeoff
by: Jasper eWinkel, et al.
Published: (2012-08-01)

Dopaminergic drug effects during reversal learning depend on anatomical connections between the orbitofrontal cortex and the amygdala.
by: Marieke E. van der Schaaf, et al.
Published: (2013-08-01)

Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
by: Gabriela Tavares, et al.
Published: (2021-09-01)

Evaluation of the efficacy and safety of bromocriptine QR in type 2 diabetes
by: Karuna Balwant Ramteke, et al.
Published: (2011-01-01)

Prolactinomas: evolution after menopause
by: Maria Susana Mallea-Gil, et al.

Effect of cholestasis on Bromocriptine-induced yawning
by: Parviz M, et al.
Published: (1998-08-01)

Evaluation of lipid profile and inflammatory parameters in female diabetes type 2 induced rabbits treated with glimepride,bromocriptine and fluoxtein
by: Duraid A. Abbas, et al.
Published: (2019-01-01)

Selection in the dopamine receptor 2 gene: a candidate SNP study
by: Tobias Göllner, et al.
Published: (2015-08-01)

Bromocriptine, a Dopamine (D2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia
by: Harish Kumar V.S., et al.
Published: (2013-09-01)

Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
by: Mojgan Sheikhpour, et al.
Published: (2020-01-01)

A Case Report of Trigeminal Neuralgia after Taking Bromocriptine
by: Reza Bavarsad Shahripour
Published: (2011-07-01)

Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus
by: Mitra Niafar, et al.
Published: (2016-03-01)

Single and Binge Methamphetamine Administrations Have Different Effects on the Levels of Dopamine D2 Autoreceptor and Dopamine Transporter in Rat Striatum
by: Heli Chauhan, et al.
Published: (2014-04-01)

Bromocriptine in type 2 diabetes mellitus
by: C Shivaprasad, et al.
Published: (2011-01-01)

Body weight changes in female patients with prolactinoma treated with bromocriptin
by: Z. Velija-Ašimi;
Published: (2007-08-01)

Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
by: Mojgan Sheikhpour, et al.
Published: (2020-01-01)

Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus
by: Bindu Chamarthi, et al.
Published: (2020-01-01)

Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas
by: Renata S. Auriemma, et al.
Published: (2019-05-01)

Repurposing of Bromocriptine for Cancer Therapy
by: Ean-Jeong Seo, et al.
Published: (2018-10-01)

Abulia: The Pathology of "Will" and Dopaminergic Dysfunction in Brain-Injured Patients
by: Samir ALl-Adawi, et al.
Published: (1999-01-01)

Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma
by: Motoyuki Igata, et al.
Published: (2021-04-01)

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control
by: Yogendra Keche
Published: (2010-01-01)

Role of bromocriptine in multi-spectral manifestations of traumatic brain injury
by: Sunil Munakomi, et al.
Published: (2017-04-01)

Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease
by: Yasir Hasan Siddique, et al.
Published: (2016-01-01)

Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report
by: Saya Hakata, et al.
Published: (2019-06-01)

Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus
by: Briones-Aranda Alfredo, et al.
Published: (2018-03-01)

SEX DIFFERENCES IN DOPAMINE REUPTAKE PATHWAYS OF THE NIGROSTRIATAL DOPAMINERGIC SYSTEM IN MICE
by: Bhatt, Sandeep
Published: (2006)

The dopamine agonist bromocriptine differentially affects fronto-striatal functional connectivity during working memory.
by: Deanna L. Wallace, et al.
Published: (2011-03-01)

D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD
by: Xueliang Fan, et al.
Published: (2010-01-01)

Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study
by: Amer Budayr, et al.
Published: (2020-02-01)

Dopaminergic control of attentional flexibility: inhibition of return is associated with the dopamine transporter gene (DAT1)
by: Lorenza S Colzato, et al.
Published: (2010-07-01)

The Effect of Concurrent Administration of Metoclopramide, Bromocriptine and Cumin Essential Oils on Rat Ovary
by: F Abbasi Hormozi, et al.
Published: (2016-07-01)

Effectiveness of Bromocriptine, Fluoxetine and Nortriptyline in Ameliorating the Negative Symptoms of Schizophrenia
by: Saied Shoja-Shefti
Published: (2004-06-01)

A KINDER, GENTLER DOPAMINE . . .HIGHLIGHTING DOPAMINE'S ROLE IN BEHAVIORAL FLEXIBILITY
by: Jeff A Beeler, et al.
Published: (2014-01-01)